Skip to main content
. 2017 Nov 30;18(Suppl 1):111. doi: 10.1186/s10194-017-0817-z

Fig. 1 (abstract P123).

Fig. 1 (abstract P123).

Headache-day frequency calculated using the patient-reported estimate of number of days in a month with headache. Wilcoxon signed-rank test for change versus baseline (level of significance: 5%). The number of patients in follow-up (FU) sessions 9-12 were: FU9, n=67; FU10, n=38; FU11, n=21; FU12, n=16. The mean change from baseline for FU sessions 9-12 were each significant (*P<0.001)